Cytokinetics, Incorporated (NASDAQ:CYTK) Director Sells $271,100.00 in Stock
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) Director B Lynne Parshall sold 5,000 shares of the firm’s stock in a transaction dated Monday, July 1st. The shares were sold at an average price of $54.22, for a total value of $271,100.00. Following the completion of the transaction, the director now owns 20,600 shares of the […]
More Stories
UFP Industries (NASDAQ:UFPI) Reaches New 1-Year High – Time to Buy?
UFP Industries, Inc. (NASDAQ:UFPI – Get Free Report) reached a new 52-week high on Monday . The stock traded as...
Uber Technologies (NYSE:UBER) Trading 1.9% Higher on Analyst Upgrade
Uber Technologies, Inc. (NYSE:UBER – Get Free Report) shares traded up 1.9% during trading on Monday after Tigress Financial raised...
Sixth Street Specialty Lending (NYSE:TSLX) Trading Up 0.9% – Time to Buy?
Sixth Street Specialty Lending, Inc. (NYSE:TSLX – Get Free Report)’s share price traded up 0.9% during trading on Monday ....
Diana Shipping Inc. to Issue Quarterly Dividend of $0.01 (NYSE:DSX)
Diana Shipping Inc. (NYSE:DSX – Get Free Report) announced a quarterly dividend on Monday, November 25th,NASDAQ Dividends reports. Stockholders of...
Agilent Technologies (NYSE:A) Updates FY 2025 Earnings Guidance
Agilent Technologies (NYSE:A – Get Free Report) issued an update on its FY 2025 earnings guidance on Monday morning. The...
Jamieson Wellness (TSE:JWEL) Sets New 52-Week High After Analyst Upgrade
Shares of Jamieson Wellness Inc. (TSE:JWEL – Get Free Report) reached a new 52-week high during trading on Monday after...